Zymeworks Inc. filed Definitive Additional Materials (DEFA14A) on October 26, 2026, providing stockholders and registered shareholders with notice of the company's Annual Meeting of Stockholders to be held on December 15, 2026, at 9:00 a.m. Pacific Time, conducted virtually via the Internet.

Key Highlights

  • Meeting date and format: The annual meeting is scheduled for December 15, 2026, at 9:00 a.m. PT, held entirely online at meetnow.global/M45Z77N.
  • Director nominees: Three nominees are proposed for election: Brian N. Cherry, Gregory A. Ciongoli, and Oleg Nodelman.
  • Board declassification: Proposal 5 asks stockholders to approve an amendment and restatement of the certificate of incorporation to declassify the board of directors.
  • New equity plan: Proposal 4 seeks approval of a 2026 Employee Stock Purchase Plan.
  • Auditor ratification: Proposal 6 covers the ratification of KPMG LLP, chartered professional accountants, as auditors for the year ending December 31, 2026.
  • Materials request deadline: Stockholders must request paper copies of proxy materials by December 5, 2026, to facilitate timely delivery.
  • Board recommendations: The Board of Directors recommends a vote FOR all nominees and FOR Proposals 2, 4, 5, and 6, and 1 YEAR for Proposal 3.

Zymeworks 2026 Annual Meeting: Proposals and Voting Details

According to the filing, Zymeworks Inc. (NASDAQ:ZYME), a biopharmaceutical company, is presenting stockholders with six proposals at its upcoming virtual annual meeting. The Board of Directors has recommended approval of all items on the agenda. The meeting is accessible online, and the company disclosed that stockholders cannot vote by returning the notice itself; they must vote online or obtain a paper copy of the proxy materials and submit a proxy card or voting instruction card.

The filing outlines that the two advisory compensation proposals are standard executive pay and frequency votes under applicable securities regulations. Proposal 3, regarding the preferred frequency of advisory votes on named executive officer compensation, carries a board recommendation of 1 YEAR. For registered shareholders, voting instruction cards must be received by 11:59 p.m. ET on December 14, 2026, whether submitted by mail, internet, or telephone.

The filing also notes that the company is using a notice-and-access approach, consistent with U.S. Securities and Exchange Commission rules, meaning stockholders will not automatically receive a physical copy of proxy materials unless they specifically request one. Proxy materials, including the Annual Report on Form 10-K, the Proxy Statement, and the Notice of Meeting, are available on the Internet at the address listed in the filing. Non-registered shareholders who hold shares through an intermediary such as a bank, trust company, or broker must follow the voting instructions provided by that intermediary.

What Was Disclosed

Zymeworks filed Definitive Additional Materials on October 26, 2026, providing notice of its December 15, 2026, virtual annual meeting. The filing details six proposals, voting deadlines, board recommendations, and instructions for accessing proxy materials online or requesting paper copies.